SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kopran - Quaterly Results

11 Feb 2025 Evaluate
The sales for the December 2024 quarter moved down to Rs. 719.38 millions as compared to Rs. 823.34 millions during the year-ago period.Net profit declined -12.96% to Rs. 74.07 millions from Rs. 85.10 millions.Operating profit for the quarter ended December 2024 decreased to 121.45 millions as compared to 133.54 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 719.38 823.34 -12.63 1950.75 2468.33 -20.97 3374.56 2730.95 23.57
Other Income 7.46 12.91 -42.22 39.87 85.62 -53.43 167.11 160.86 3.89
PBIDT 121.45 133.54 -9.05 303.55 301.47 0.69 536.37 439.99 21.91
Interest 9.86 10.25 -3.80 25.09 27.22 -7.83 45.01 26.72 68.45
PBDT 111.59 123.29 -9.49 278.46 274.25 1.54 491.36 413.27 18.90
Depreciation 13.32 11.72 13.65 37.60 34.59 8.70 46.20 44.12 4.71
PBT 98.27 111.57 -11.92 240.86 239.66 0.50 445.16 369.15 20.59
TAX 24.20 26.47 -8.58 58.29 46.39 25.65 98.79 56.63 74.45
Deferred Tax 0.48 -1.50 -132.00 -0.68 -2.13 -68.08 -2.03 -2.09 -2.87
PAT 74.07 85.10 -12.96 182.57 193.27 -5.54 346.37 312.52 10.83
Equity 482.11 482.11 0.00 482.11 482.11 0.00 482.11 482.11 0.00
PBIDTM(%) 16.88 16.22 4.09 15.56 12.21 27.41 15.89 16.11 -1.35

Kopran Share Price

159.60 4.70 (3.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×